Toni Choueiri, MD's Avatar

Toni Choueiri, MD

@drchoueiri.bsky.social

Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Kohberg Professor of Medicine, Harvard Medical School

839 Followers  |  64 Following  |  36 Posts  |  Joined: 29.11.2024  |  1.9919

Latest posts by drchoueiri.bsky.social on Bluesky

Preview
Empowering Oncologists: How far can purpose and passion take you in cancer care? - OncoDaily Empowering Oncologists: How far can purpose and passion take you in cancer care? / cancer, Empowering Oncologists, Jasmine Kamboj, OncoDaily, Oncology, Toni

Empowering Oncologists: How far can purpose and passion take you in cancer care?
@drchoueiri.bsky.social

oncodaily.com/dialogues/31...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EmpoweringOncologists

25.06.2025 14:13 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Preview
Chain Reaction: The Belzutifan Journey | Dana-Farber Cancer Institute Basic science discoveries made by Dana-Farber's William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.

In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use.

05.06.2025 22:00 β€” πŸ‘ 7    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

@drchoueiri.bsky.social‬ discusses promising results from the phase 1 ARC-20 study, exploring the combination of Casdatifan and cabozantinib in patients with previously treated clear cell renal cell carcinoma. #ASCO25

01.06.2025 16:54 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Support Kancer Killers - Pickleball for a Purpose 2025 We're excited to join this incredible initiative! This organization's mission is very important to us and we're proud to help them make a difference. Please support us by giving to our page. Every dol...

1 week left to support @danafarber.bsky.social & Gronk Nation Youth Foundation! Help us finish strong + take on @RobGronkowski!

🎟️ $187+ = ticket to the event
🏈 $100+ = chance to win signed Gronk football
πŸ‘€ Gronk, Edelman, Ninkovich, Chung
πŸ“… Deadline: May 20

πŸ”— charity.pledgeit.org/pickleball/t...

14.05.2025 05:05 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 3    πŸ“Œ 0
Post image

β€œI can imagine no heroism greater than motherhood." - Happy Mothers day mom and all the mothers in the world ! #HappyMothersDay2025

11.05.2025 13:08 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 3    πŸ“Œ 0
#AACR25 2025 Scientific Achievement Awards

#AACR25 2025 Scientific Achievement Awards

We’re getting ready to wrap up #AACR25 today, but not before once again congratulating @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social and Alice T. Shaw, MD, PhD, for receiving @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om

30.04.2025 15:00 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Thank you @theaacr.bsky.social for the Waun Ki Hong Award!

My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago!

cc: @danafarber.bsky.social

25.04.2025 20:27 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

Our own @danafarber.bsky.social Dr. @NarjustFlorezMD is running for @iaslc.bsky.social Board. Let us support NJ! @narjustflorezmd.bsky.social

@danafarbernews.bsky.social

19.04.2025 19:14 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

Thank you @theaacr.bsky.social for this honor !

14.04.2025 16:36 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
A Year of Advances in Genitourinary Cancer Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to res...

β€œOur focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @drchoueiri.bsky.social. Learn about the research advancements our Lank Center for Genitourinary Oncology has made this past year.

11.04.2025 15:01 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1
Post image

πŸ’¬ Transatlantic Exchange : interview croisΓ©e du Dr @drchoueiri.bsky.social & du Pr Karim Fizazi.

Le 19 mars s’est tenue Γ  Paris la 4e Γ©dition des Transatlantic Exchanges, une journΓ©e scientifique co-organisΓ©e par @gustaveroussy.fr et le @danafarber.bsky.social.

⬇

11.04.2025 11:22 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0

β€œIt may be that the satisfaction I need depends on my going away, so that when I've gone and come back, I'll find it at home”—Rumi, 13th century

05.04.2025 11:07 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

Another year, another #pickeball tournament with our good friend Rob Gronkowski #DaGronk to benefit our Research and Gronk Nation Youth Foundation. Join me and
donate at:

charity.pledgeit.org/pickleball/@to…

#curecancer #beatgronk

02.04.2025 20:58 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

This weekend, thanks to the support of the @redsox.com, @danafarber.bsky.social & @thejimmyfund.bsky.social gathered @fenwaypark.bsky.social to celebrate the impact of our Campaign. We celebrated our donors who help us defy Cancer together !

01.04.2025 01:30 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

Yesterday, @drchoueiri.bsky.social and Karim Fizazi, MD, PhD, kicked off The Fourth Transatlantic Exchange in Oncology: Radiopharmaceutical Therapy Meets Oncology. Learn more about the collaborative event with @gustaveroussy.fr: bit.ly/42fC69Z

20.03.2025 13:02 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

Thank you @TownofWestwood and Lenny Strauss for highlighting our @PanMass journey the past several years, both @mvmombo and I. We are committed @DanaFarber to end Cancer!

hometownweekly.net/westwood/dr-ch…

Our @CowbellTeam Link for donations to cure Cancer: teammorecowbell.com/

14.03.2025 14:36 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial – VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful...

www.globenewswire.com/news-release...

11.03.2025 18:38 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Happy International Women’s day to the wonderful GU Oncology Women’s @danafarber.bsky.social (front row)

08.03.2025 21:59 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study Background Data on the safety profiles and clinical outcomes of patients with solid tumors and cardiac metastasis treated with immune checkpoint inhibitors (ICIs) are limited. Methods This is an inte...

Our new paper in JITC with a group of fine international friends, mentees and colleagues about immunotherapy in patients with cardiac metastasis.

jitc.bmj.com/content/13/3/e…

@danafarber.bsky.social jitc.bmj.com/content/13/3...64

07.03.2025 02:03 β€” πŸ‘ 7    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

Promising results: Adjuvant neoantigen vaccination prevents recurrence of kidney cancer bit.ly/3EUpSKGΒ Β @danafarber.bsky.social Β @braunmdphd.bsky.social Β @yalecancer.bsky.social Β @drchoueiri.bsky.social

19.02.2025 19:01 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

#GU25 was an outstanding @ascocancer.bsky.social meeting: catching up with friends/ colleagues, watching mentees grow, learn up-to-date GU cancers management, and presenting a new HIF-2 inhibitor (casdatifan) data. Energized! The future is bright!

@danafarber.bsky.social @jrgralow.bsky.social

16.02.2025 21:53 β€” πŸ‘ 13    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0

Great @ascocancer.bsky.social #GU25 catching up with many friends ! @jrgralow.bsky.social

15.02.2025 23:20 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

Updated results from the phase 2 LITESPARK-003 study on belzutifan + cabozantinib in advanced ccRCC patients! πŸ“ŠπŸ’‘ Key insights into combination therapy and improved outcomes @ascocancer.bsky.social #GU25 @drchoueiri.bsky.social

15.02.2025 18:33 β€” πŸ‘ 6    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

Great to have @drchoueiri.bsky.social stop by our poster @ascocancer.bsky.social #GU25! Appreciate the insightful discussion and your time.

15.02.2025 18:43 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Personalized Vaccine May Help Prevent Kidney Cancer Recurrence None of the nine patients who received the vaccine after surgery experienced recurrence over three years.

A customized kidney cancer vaccine made from patients’ tumors looked promising in a small study, @drchoueiri.bsky.social et al report in @nature.com. None of the 9 treated people experienced recurrence. Larger trial of mRNA vaccine underway.
www.cancerhealth.com/article/pers...

15.02.2025 22:35 β€” πŸ‘ 18    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Preview
Personalized cancer vaccine shows potential in kidney cancer In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

In @statnews.com: 9 patients w/advanced kidney cancer who received an experimental vaccine tailored to tumors’ specific mutations mounted an immune response & remained cancer-free for 3 years. @drchoueiri.bsky.social of @danafarber.bsky.social explains the early-phase clinical trial. bit.ly/4aNK9xs

06.02.2025 02:28 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
A personalized cancer vaccine to prevent the return of high-risk kidney cancer A phase I clinical trial supports the safety and feasibility of a vaccine to limit disease recurrence in people with kidney cancer.

It's an incredible proof-of-principle! Fantastic work led by @drchoueiri.bsky.social
Personalised cancer vaccines in the adjuvant setting!!

www.nature.com/articles/d41...

07.02.2025 10:31 β€” πŸ‘ 6    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
A personalized cancer vaccine to prevent the return of high-risk kidney cancer A phase I clinical trial supports the safety and feasibility of a vaccine to limit disease recurrence in people with kidney cancer.

A personalized cancer vaccine to prevent the return of high-risk kidney cancer @nature.com @braunmdphd.bsky.social
@drchoueiri.bsky.social
www.nature.com/articles/d41...
www.nature.com/articles/s41...

05.02.2025 19:00 β€” πŸ‘ 9    πŸ” 5    πŸ’¬ 1    πŸ“Œ 0
Cancer vaccine shows promise for patients with stage III and IV kidney cancer | Dana-Farber Cancer Institute All nine patients treated at Dana-Farber Cancer Institute in a phase 1 trial of a personalized cancer vaccine for patients with stage III or IV kidney cancer with a high risk of recurrence, generated ...

Successful anti-cancer immune responses reported in phase 1 trial of a personalized cancer vaccine for #kidneycancer. Research in Nature led by @drchoueiri.bsky.social #PatrickOtt #CatherineWu #DerinKeskin (all of @danafarber.bsky.social) and David Braun of @yalecancer.bsky.social. bit.ly/3CDIT3n

05.02.2025 18:52 β€” πŸ‘ 13    πŸ” 5    πŸ’¬ 1    πŸ“Œ 2

Congrats @drchoueiri.bsky.social! Tremendous translational clinical trial with truly elegant science supporting this concept! Excited for the larger studies ongoing for patients in critical need of curative therapies. @theaacr.bsky.social @helloeacr.bsky.social @ascocancer.bsky.social

05.02.2025 19:30 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

@drchoueiri is following 20 prominent accounts